Swimming the Catalan coast to raise funds for TRICALS

To raise funds for TRICALS, Daniel Rossinés has taken on an epic…

Words Lucie van Leeuwen.Published October 1, 2020
Swimming the Catalan coast to raise funds for TRICALS

To raise funds for TRICALS, Daniel Rossinés has taken on an epic challenge. In 24 consecutive days he is swimming the entire Catalan coast: 400 km. He started in Portbou (Girona) on the 17th of September and will finish in Les Cases d’Alcanar (Tarragona).

Daniel Rossinés started to raise funds for ALS research in 2014 when he learned that his good friend was diagnosed with ALS. He then decided to combine his love for open water swimming with his skills in business management to organise fundraising challenges. For his next brave effort, the ‘Upside Down Challenge’, he swims along the Catalan coast from north to south. Other people have also joined him at several stages of his journey so far.

Besides raising money, this action also aims to raise more awareness about ALS. His initiative has already received a lot of media attention in Spain and is sponsored by former footballer and coach Juan Carlos Unzué, who announced last June that he suffers from ALS. The children of the sportsman have even accompanied Daniel Rossinés on one day of his swim.

At this moment, Daniel Rossinés has swum over 200 km and raised more than €48.000. The goal is to raise €200.000 – €1 for every swimming stroke. All the money raised will be managed by Fundación Luzón and goes towards research activities of TRICALS. We are very grateful for this courageous initiative and wish Daniel all the strength to face the second half of his journey ahead. We thank him, and everyone who donated or joined him in this challenge, for their support in our mission to speed up the development of new therapies for people living with ALS.

Donations can be made by clicking this link (in Spanish).

Updates of the project are regularly shared on the Upside Down Challenge Instagram account.


Share

Related news

Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its […]
Retrotope announces initiation of RT001 study in people with ALS
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in […]
Virtual ENCALS meeting 2021
Virtual ENCALS meeting 2021
This year, ENCALS (European Network to Cure ALS) will be organising their […]
New centres in Portugal and Spain join TRICALS network
New centres in Portugal and Spain join TRICALS network
We are very excited to announce that recently two new expert ALS […]